Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Withdrawn 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Breast 1

Conditions

Vomiting 1Rectal Neoplasms 1Patient Compliance 1Nausea 1Liver Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Acupuncture Points × Clear all
NCT00430313 2023-03-29

Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin

M.D. Anderson Cancer Center

Phase NA Withdrawn
Gastrointestinal

Liver Neoplasms, Nausea, Vomiting

NCT05041751 2022-05-17

Myofascial Release or Trigger Point Injections for the Reduction of Post-Mastectomy Pain Syndrome

M.D. Anderson Cancer Center

Phase NA Withdrawn
Breast

Breast Neoplasms

NCT04749381 2021-02-11

RCT

Peking University Cancer Hospital & Institute

Phase 2 Unknown
264 enrolled
Gastrointestinal

Patient Compliance, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡